Acute Respiratory Distress Syndrome: Bench‐to‐Bedside Approaches to Improve Drug Development

Despite 50 years of extensive research, no definite drug is currently available to treat acute respiratory distress syndrome (ARDS), and the supportive therapies remain the mainstay of treatment. To improve drug development for ARDS, researchers need to deeply analyze the “omics” approaches, reevalu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Pharmacol Ther
Auteurs principaux: Hussain, Musaddique, Xu, Chengyun, Ahmad, Mashaal, Majeed, Abdul, Lu, Meiping, Wu, Xiling, Tang, Lanfang, Wu, Ximei
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Reviews
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7162218/
https://ncbi.nlm.nih.gov/pubmed/29484641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1034
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires